Oryzon Genomics SA

NEW
XMAD:ORY (Spain)  
€ 2.832 -0.26 (-8.41%) Jul 1
At Loss
P/B:
1.87
Market Cap:
€ 219.52M ($ 250.47M)
Enterprise V:
€ 198.13M ($ 226.07M)
Volume:
2.97M
Avg Vol (2M):
418.25K
Trade In:
Volume:
2.97M
At Loss
Avg Vol (2M):
418.25K

Oryzon Genomics SA (XMAD:ORY) Dividend

Oryzon Genomics SA (XMAD:ORY) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -11.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XMAD:ORY Dividend

Does Oryzon Genomics SA (XMAD:ORY) pay a dividend?

Oryzon Genomics SA (XMAD:ORY) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Oryzon Genomics SA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Oryzon Genomics SA has returned capital to shareholders via buybacks at a rate of -11.4% over the past 3 years.

What are dividend-paying alternatives to Oryzon Genomics SA?

For dividend-paying alternatives in Oryzon Genomics SA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.